Table 3 Univariate and multivariate analyses of risk factors with and OS in the training cohort.

From: Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma

Variables

HR (95% CI)

P value

Univariate analyses

Age (years) (> 60 vs. ≤ 60)

1.470 (0.952, 2.270)

0.083

Gender (male vs. female)

0.851 (0.546, 1.326)

0.476

BMI

0.969 (0.928, 2.535)

0.146

Child–Pugh classification (B and C vs. A)

2.232 (0.927, 5.372)

0.073

Alcohol consumption (yes vs. no)

1.262 (0.812, 1.963)

0.302

Hepatitis B (yes vs. no)

0.284 (0.153, 0.525)

< 0.001

Hepatitis C (yes vs. no)

1.078 (0.553, 2.104)

0.825

Histologic grade (G3-4 vs. G1-2)

0.922 (0.590, 1.439)

0.720

Microvascular invasion (yes vs. no)

1.527 (0.917, 2.543)

0.103

AJCC tumor stage (III and IV vs. I and II)

3.317 (2.084, 5.278)

< 0.001

Risk score

2.714 (2.163, 3.405)

< 0.001

Multivariate analyses

Hepatitis B (yes vs. no)

0.451 (0.227, 0.894)

0.023

AJCC tumor stage (III and IV vs. I and II)

1.917 (1.154, 3.182)

0.012

Risk score

2.163 (1.670, 2.800)

< 0.001

  1. HR, hazard ratio; CI, confidence interval; OS, overall survival; BMI, body mass index; AJCC, American Joint Committee on Cancer.